Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,575.00
-120.00 (-2.56%)
Jun 10, 2026, 3:30 PM KST

Bio Plus Revenue

Bio Plus had revenue of 26.51B KRW in the quarter ending March 31, 2026, with 15.35% growth. This brings the company's revenue in the last twelve months to 94.42B, up 18.36% year-over-year. In the year 2025, Bio Plus had annual revenue of 90.90B with 36.87% growth.

Revenue (ttm)
94.42B
Revenue Growth
+18.36%
P/S Ratio
2.98
Revenue / Employee
n/a
Employees
n/a
Market Cap
281.55B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202590.90B24.49B36.87%
Dec 31, 202466.41B1.37B2.10%
Dec 31, 202365.04B8.32B14.68%
Dec 31, 202256.72B19.30B51.58%
Dec 31, 202137.42B13.05B53.56%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
i-SENS314.31B
InBody Co.,Ltd246.81B
WON TECH159.67B
DRTECH122.78B
Osang Healthcare Co.,Ltd119.38B
LabGenomics84.19B
SEERS76.63B
Curexo70.92B
Revenue Rankings